Cellular signaling by fibroblast growth factor receptors
- PMID: 15863030
- DOI: 10.1016/j.cytogfr.2005.01.001
Cellular signaling by fibroblast growth factor receptors
Abstract
The 22 members of the fibroblast growth factor (FGF) family of growth factors mediate their cellular responses by binding to and activating the different isoforms encoded by the four receptor tyrosine kinases (RTKs) designated FGFR1, FGFR2, FGFR3 and FGFR4. Unlike other growth factors, FGFs act in concert with heparin or heparan sulfate proteoglycan (HSPG) to activate FGFRs and to induce the pleiotropic responses that lead to the variety of cellular responses induced by this large family of growth factors. A variety of human skeletal dysplasias have been linked to specific point mutations in FGFR1, FGFR2 and FGFR3 leading to severe impairment in cranial, digital and skeletal development. Gain of function mutations in FGFRs were also identified in a variety of human cancers such as myeloproliferative syndromes, lymphomas, prostate and breast cancers as well as other malignant diseases. The binding of FGF and HSPG to the extracellular ligand domain of FGFR induces receptor dimerization, activation and autophosphorylation of multiple tyrosine residues in the cytoplasmic domain of the receptor molecule. A variety of signaling proteins are phosphorylated in response to FGF stimulation including Shc, phospholipase-Cgamma, STAT1, Gab1 and FRS2alpha leading to stimulation of intracellular signaling pathways that control cell proliferation, cell differentiation, cell migration, cell survival and cell shape. The docking proteins FRS2alpha and FRS2beta are major mediators of the Ras/MAPK and PI-3 kinase/Akt signaling pathways as well as negative feedback mechanisms that fine-tune the signal that is initiated at the cell surface following FGFR stimulation.
Similar articles
-
Mechanisms underlying differential responses to FGF signaling.Cytokine Growth Factor Rev. 2005 Apr;16(2):233-47. doi: 10.1016/j.cytogfr.2005.01.007. Epub 2005 Mar 5. Cytokine Growth Factor Rev. 2005. PMID: 15863038 Review.
-
Fibroblast growth factors and their receptors in the central nervous system.Cell Tissue Res. 2003 Aug;313(2):139-57. doi: 10.1007/s00441-003-0756-7. Epub 2003 Jul 5. Cell Tissue Res. 2003. PMID: 12845521 Review.
-
Extracellular interactome of the FGF receptor-ligand system: complexities and the relative simplicity of the worm.Dev Dyn. 2009 Feb;238(2):277-93. doi: 10.1002/dvdy.21757. Dev Dyn. 2009. PMID: 18985724 Review.
-
Fibroblast growth factors and their receptors in cancer.Biochem J. 2011 Jul 15;437(2):199-213. doi: 10.1042/BJ20101603. Biochem J. 2011. PMID: 21711248 Review.
-
FGF signaling network in the gastrointestinal tract (review).Int J Oncol. 2006 Jul;29(1):163-8. Int J Oncol. 2006. PMID: 16773196 Review.
Cited by
-
Investigation of FGFR2-IIIC signaling via FGF-2 ligand for advancing GCT stromal cell differentiation.PLoS One. 2012;7(10):e46769. doi: 10.1371/journal.pone.0046769. Epub 2012 Oct 11. PLoS One. 2012. Retraction in: PLoS One. 2019 Jul 23;14(7):e0220356. doi: 10.1371/journal.pone.0220356. PMID: 23071632 Free PMC article. Retracted.
-
Characterization of clostridium botulinum neurotoxin serotype A (BoNT/A) and fibroblast growth factor receptor interactions using novel receptor dimerization assay.Sci Rep. 2021 Apr 9;11(1):7832. doi: 10.1038/s41598-021-87331-7. Sci Rep. 2021. PMID: 33837264 Free PMC article.
-
Membrane and integrative nuclear fibroblastic growth factor receptor (FGFR) regulation of FGF-23.J Biol Chem. 2015 Apr 17;290(16):10447-59. doi: 10.1074/jbc.M114.609230. Epub 2015 Mar 9. J Biol Chem. 2015. PMID: 25752607 Free PMC article.
-
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients.Breast Cancer Res Treat. 2020 Nov;184(2):311-324. doi: 10.1007/s10549-020-05865-2. Epub 2020 Aug 27. Breast Cancer Res Treat. 2020. PMID: 32852708 Free PMC article.
-
FGFR2 and NOTCH1 Expression Inversely Correlated in Progressive Cutaneous Carcinogenesis in an Experimental Mouse Model.J Pers Med. 2024 Jul 5;14(7):729. doi: 10.3390/jpm14070729. J Pers Med. 2024. PMID: 39063983 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous